Last checked at 
(Alliance News) - Oncimmune Holdings PLC on Monday said it has added two members to its senior leadership team, effective on October.
The immunodiagnostics company has appointed Tariq Sethi has its scientific chief and Matthew Luttrell as its commercial chief.
Sethi was formerly vice president of AstraZeneca PLC's Respiratory Immunology Autoimmunity Translational Medicine Unit. He will join the company next Tuesday.
Luttrell, who also joins next Tuesdat, is a "seasoned health and life science commercial executive". He was formerly the senior brand manager for GlaxoSmithKline PLC's oncology division.
Chief Executive Adam Hill said: "The appointments of Sethi and Luttrell add yet more expertise and depth to our leadership teams as we establish Oncimmune as a key player in supporting critical clinical decisions across the cancer care pathway.
"I'm delighted to welcome them and am pleased that Oncimmune's potential attracts such high quality, experienced and seasoned professionals."
Shares in the company were 1.6% higher at 91.40 pence each in London on Monday afternoon.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
